Evidence map›Paper›PMID 34227061›Full record

ArticleMolecular neurobiology2021

W246G Mutant ELOVL4 Impairs Synaptic Plasticity in Parallel and Climbing Fibers and Causes Motor Defects in a Rat Model of SCA34.

Raghavendra Y Nagaraja, David M Sherry, Jennifer L Fessler, Megan A Stiles, Feng Li, Karanpreet Multani, Albert Orock, Mohiuddin Ahmad, Richard S Brush, Robert E Anderson and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular neurobiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Synapse-Specific Defects in Synaptic Transmission in the Cerebellum of W246G Mutant ELOVL4 Rats-a Model of Human SCA34.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Selective Ablation ofThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Raghavendra Y NagarajaBiochemistry & Molecular Biology, University of Oklahoma Health Sciences Center, 608 Stanton L. Young Blvd, DMEI 428PP, Oklahoma City, OK, 73104, USA.ORCID https://orcid.org/0000-0002-8906-5251
David M SherryNeuroscience Program, University of Oklahoma Health Sciences Center, 608 Stanton L. Young Blvd, DMEI 428PP, Oklahoma City, OK, 73104, USA.ORCID https://orcid.org/0000-0003-1568-0611
Jennifer L FesslerCell Biology, University of Oklahoma Health Sciences Center, 608 Stanton L. Young Blvd, DMEI 428PP, Oklahoma City, OK, 73104, USA.ORCID https://orcid.org/0000-0003-1987-9513
Megan A StilesOphthalmology, University of Oklahoma Health Sciences Center, 608 Stanton L. Young Blvd, DMEI 428PP, Oklahoma City, OK, 73104, USA.ORCID https://orcid.org/0000-0002-0757-6657
Feng LiOphthalmology, University of Oklahoma Health Sciences Center, 608 Stanton L. Young Blvd, DMEI 428PP, Oklahoma City, OK, 73104, USA.ORCID https://orcid.org/0000-0002-7766-8047
Karanpreet MultaniOphthalmology, University of Oklahoma Health Sciences Center, 608 Stanton L. Young Blvd, DMEI 428PP, Oklahoma City, OK, 73104, USA.ORCID https://orcid.org/0000-0002-1422-0130
Albert OrockNeuroscience Program, University of Oklahoma Health Sciences Center, 608 Stanton L. Young Blvd, DMEI 428PP, Oklahoma City, OK, 73104, USA.ORCID https://orcid.org/0000-0002-1877-9548
Mohiuddin AhmadNeuroscience Program, University of Oklahoma Health Sciences Center, 608 Stanton L. Young Blvd, DMEI 428PP, Oklahoma City, OK, 73104, USA.ORCID https://orcid.org/0000-0002-0976-9620
Richard S BrushOphthalmology, University of Oklahoma Health Sciences Center, 608 Stanton L. Young Blvd, DMEI 428PP, Oklahoma City, OK, 73104, USA.ORCID https://orcid.org/0000-0002-8527-5315
Robert E AndersonNeuroscience Program, University of Oklahoma Health Sciences Center, 608 Stanton L. Young Blvd, DMEI 428PP, Oklahoma City, OK, 73104, USA.ORCID https://orcid.org/0000-0001-5664-6968
Martin-Paul AgbagaNeuroscience Program, University of Oklahoma Health Sciences Center, 608 Stanton L. Young Blvd, DMEI 428PP, Oklahoma City, OK, 73104, USA. Martin-Paul-Agbaga@ouhsc.edu.ORCID http://orcid.org/0000-0002-1920-915X
Ferenc DeákBiochemistry & Molecular Biology, University of Oklahoma Health Sciences Center, 608 Stanton L. Young Blvd, DMEI 428PP, Oklahoma City, OK, 73104, USA. FDeak@augusta.edu.ORCID https://orcid.org/0000-0003-1677-2518
Dean McGee Eye Institute · USUniversity of Oklahoma Health Sciences Center · USAugusta University · US

Funding

ZEBRAFISH INTERNATIONAL RESOURCE CENTERP40RR012546 · NCRR · UNIVERSITY OF OREGON · PI WESTERFIELD, MONTE · 1998 to 2011
$21.9M
Transgenic Mouse and Biobank CoreP01CA095616 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DEPINHO, RONALD ANTHONY · 2003 to 2012
$20.3M
Visualizing insulin actions on neuronal metabolism and function using fluorescent biosensorsP20GM125528 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Veronica Galvan, William Edmund Sonntag · 2019 to 2026
$17.8M
UC Davis/NIH NeuroMab FacilityU24NS050606 · NINDS · UNIVERSITY OF CALIFORNIA DAVIS · PI TRIMMER, JAMES S · 2005 to 2014
$15.6M
P30-CENTER CORE GRANT FOR VISION RESEARCHP30EY021725 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Michelle C Callegan, MICHAEL H ELLIOTT · 2011 to 2026
$10.5M
CORE--MOLECULAR BIOLOGYP30EY012190 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ANDERSON, ROBERT E · 1999 to 2009
$5.2M
Role of VAMP1 in synaptic transmission and Alzheimer's dementiaR01AG062655 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI DEAK, FERENC · 2020 to 2024
$1.9M
Essential Role of Very Long Chain Fatty Acids in Retinal FunctionR01EY030513 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI AGBAGA, MARTIN-PAUL · 2019 to 2023
$1.8M
Defining the Mechanism of Altered Very Long Chain Fatty Acid Metabolism in Neuro-Ichthyotic Disorders.R21AR076035 · NIAMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI AGBAGA, MARTIN-PAUL · 2019 to 2020
$351k
NCI NIH HHS P01 CA095616NCRR NIH HHS P40 RR012546NEI NIH HHS P30 EY012190NEI NIH HHS P30 EY021725NEI NIH HHS R01 EY030513NIAMS NIH HHS R21 AR076035NIA NIH HHS R01 AG062655NIGMS NIH HHS P20 GM125528NINDS NIH HHS U24 NS050606
6 · The paper itself

Abstract

Spinocerebellar ataxia (SCA) is a neurodegenerative disorder characterized by ataxia and cerebellar atrophy. A number of different mutations gives rise to different types of SCA with characteristic ages of onset, symptomatology, and rates of progression. SCA type 34 (SCA34) is caused by mutations in ELOVL4 (ELOngation of Very Long-chain fatty acids 4), a fatty acid elongase essential for biosynthesis of Very Long Chain Saturated and Polyunsaturated Fatty Acids (VLC-SFA and VLC-PUFA, resp., ≥28 carbons), which have important functions in the brain, skin, retina, Meibomian glands, testes, and sperm. We generated a rat model of SCA34 by knock-in of the SCA34-causing 736T>G (p.W246G) ELOVL4 mutation. Rats carrying the mutation developed impaired motor deficits by 2 months of age. To understand the mechanism of these motor deficits, we performed electrophysiological studies using cerebellar slices from rats homozygous for W246G mutant ELOVL4 and found marked reduction of long-term potentiation at parallel fiber synapses and long-term depression at climbing fiber synapses onto Purkinje cells. Neuroanatomical analysis of the cerebellum showed normal cytoarchitectural organization with no evidence of degeneration out to 6 months of age. These results point to ELOVL4 as essential for motor function and cerebellar synaptic plasticity. The results further suggest that ataxia in SCA34 patients may arise from a primary impairment of synaptic plasticity and cerebellar network desynchronization before onset of neurodegeneration and progression of the disease at a later age.

Indexed as

AnimalsCerebellumEye ProteinsFemaleMaleMembrane ProteinsMotor DisordersMutationNerve Fibers, MyelinatedNeuronal PlasticityOrgan Culture TechniquesRatsRats, Long-EvansRats, TransgenicSpinocerebellar AtaxiasElovl4 protein, mouseEye ProteinsMembrane ProteinsCerebellumElectrophysiologyElongation of Very Long Chain Fatty Acids-4 (ELOVL4)Spinocerebellar ataxia-34 (SCA34)Very Long Chain Fatty Acids (VLC-FA)

Identifiers

PMID34227061
PMCPMC8497303
OpenAlexW3132094379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.